---
title: "BRNI.US (BRNI.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BRNI.US/news.md"
symbol: "BRNI.US"
name: "BRNI.US"
parent: "https://longbridge.com/en/quote/BRNI.US.md"
datetime: "2026-03-12T16:11:04.422Z"
locales:
  - [en](https://longbridge.com/en/quote/BRNI.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BRNI.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BRNI.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/BRNI.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/BRNI.US/news.md)


# BRNI.US (BRNI.US) — Related News

### [Beroni Group Limited  Advances R&D of Enhanced COVID-19 Antigen RTK](https://longbridge.com/en/news/79405733.md)
*2023-02-08T21:55:02.000Z*
> (marketscreener.com) Beroni Group Limited , an Australia-based biopharmaceutical enterprise, announced that its enhanced